Jordan Journal of Pharmaceutical Sciences最新文献

筛选
英文 中文
Exploration of Potentially Bioactive Compounds from Fingerroot (Boesenbergia rotunda L.) as Inhibitor of Atherosclerosis-Related Proteins (CETP, ACAT1, OSC, sPLA2): An in silico Study 手指根(Boesenbergia rotunda L.)作为动脉粥样硬化相关蛋白(CETP, ACAT1, OSC, sPLA2)抑制剂的潜在生物活性化合物的探索:一项硅研究
Jordan Journal of Pharmaceutical Sciences Pub Date : 2023-09-23 DOI: 10.35516/jjps.v16i3.1609
Muhammad Hermawan Widyananda, Coni Anggie Kurniasari, Fajar Mustika Alam, Wahyu Choirur Rizky, Tim Godefridus Antonius Dings, Arif Nur Muhammad Ansori, Yulanda Antonius
{"title":"Exploration of Potentially Bioactive Compounds from Fingerroot (Boesenbergia rotunda L.) as Inhibitor of Atherosclerosis-Related Proteins (CETP, ACAT1, OSC, sPLA2): An in silico Study","authors":"Muhammad Hermawan Widyananda, Coni Anggie Kurniasari, Fajar Mustika Alam, Wahyu Choirur Rizky, Tim Godefridus Antonius Dings, Arif Nur Muhammad Ansori, Yulanda Antonius","doi":"10.35516/jjps.v16i3.1609","DOIUrl":"https://doi.org/10.35516/jjps.v16i3.1609","url":null,"abstract":"Boesenbergia rotunda L., commonly known as fingerroot, is recognized as one of Indonesia's medicinal plants with significant potential for treating various diseases, including atherosclerosis. This study aims to analyze the anti-atherosclerosis potential of bioactive compounds found in fingerroot by assessing their inhibitory effects on four proteins associated with atherosclerosis (CETP, ACAT1, OSC, and sPLA2). Bioactive compounds from B. rotunda were retrieved from the KnapSack database. The drug-likeness properties were predicted using the SwissADME web server, and the bioactivity of the compounds was assessed using the PASSOnline server. The identification of active sites on proteins and the validation of protein structures were performed using the SCFBio web server and Autodock Vina. Specific docking simulations between fingerroot compounds and the target proteins were carried out using AutoDock Vina. The analysis revealed that fingerroot contains 20 bioactive compounds with favorable drug-like properties. Among these, dihydrochrysin, sakuranetin, isopimaric acid, 2S-pinocembrin, 5,7-dihydroxy-8-C-geranylflavanone, 7,4'-dihydroxy-5-methoxyflavanone, and 5,7-dihydroxy-8,7-methoxy-5-hydroxy-8-geranylflavanone were predicted to exhibit anti-atherosclerosis activities. In the interactions with CETP, rubranine and (-)-4-hydroxypanduratin A showed the lowest binding affinity scores. Meanwhile, in interactions with ACAT1, OSC, and sPLA2, rubranine and 5,7-dihydroxy-8-C-geranylflavanone displayed the lowest binding affinities. In conclusion, fingerroot exhibits high potential as an anti-atherosclerosis agent through the inhibition of four proteins associated with atherosclerosis, as predicted through in silico analysis.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135967075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reverse Vaccinology Analysis of B-cell Epitope against Nipah Virus using Fusion Protein 融合蛋白抗尼帕病毒b细胞表位的反向疫苗学分析
Jordan Journal of Pharmaceutical Sciences Pub Date : 2023-09-23 DOI: 10.35516/jjps.v16i3.1602
Ziyan Muhammad Aqsha, Muhammad Alsyifaa Dharmawan, Viol Dhea Kharisma, Arif Nur Muhammad Ansori, Nur Imaniati Sumantri
{"title":"Reverse Vaccinology Analysis of B-cell Epitope against Nipah Virus using Fusion Protein","authors":"Ziyan Muhammad Aqsha, Muhammad Alsyifaa Dharmawan, Viol Dhea Kharisma, Arif Nur Muhammad Ansori, Nur Imaniati Sumantri","doi":"10.35516/jjps.v16i3.1602","DOIUrl":"https://doi.org/10.35516/jjps.v16i3.1602","url":null,"abstract":"Nipah virus (NiV) is an RNA virus, a pathogenic paramyxovirus that causes nonlethal respiratory illness in pigs. It was originally reported in Malaysia in 1998. NiV is considered a potential outbreak threat because it is zoonotic. However, no vaccines or antiviral drugs have been found against NiV. Therefore, the main objective is to develop effective vaccines by characterizing the fusion protein of NiV. We used a reference sequence retrieved from the National Center for Biotechnology Information (NCBI), then 3D modeled it to obtain the conserved region of the fusion protein. The interaction between the conserved region and B-cell receptors has been evaluated through a molecular docking approach. The B-cell epitope was identified using the Immune Epitope Database (IEDB) web server. As a result, we recommend Pep_D FANCISVTCQCQ as an epitope-based peptide vaccine candidate against Nipah virus. Pep D is highly immunogenic and does not cause autoimmune reactions. Pep D has the lowest binding energy for BCR molecular complexes, which can activate the transduction signal and direct B-cell immune response. However, further studies are required for confirmation (in vitro and in vivo).","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":"63 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135966858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Influence of the COVID-19 Pandemic on the Purchasing Intention of Vitamins in Kuwait using the Theory of Planned Behavior 利用计划行为理论评估COVID-19大流行对科威特维生素购买意愿的影响
Jordan Journal of Pharmaceutical Sciences Pub Date : 2023-09-23 DOI: 10.35516/jjps.v16i3.1611
Abrar Ghaith, Manal Echchad, Farah AlHaman, Raneem Al-Shalby
{"title":"Assessing the Influence of the COVID-19 Pandemic on the Purchasing Intention of Vitamins in Kuwait using the Theory of Planned Behavior","authors":"Abrar Ghaith, Manal Echchad, Farah AlHaman, Raneem Al-Shalby","doi":"10.35516/jjps.v16i3.1611","DOIUrl":"https://doi.org/10.35516/jjps.v16i3.1611","url":null,"abstract":"Using the Theory of Planned Behavior model developed by Ajzen in 1985, the authors assessed the influence of attitude (ATT) toward vitamins, health awareness (HA), perceived behavioral control (PBC), subjective norms (SN), and knowledge of COVID-19 (KN) on the purchasing intention (PI) of vitamins in Kuwait during the COVID-19 pandemic. A total of 587 adults living in Kuwait completed the online survey, which was available in both Arabic and English. The measured variables included health awareness, attitude, knowledge about COVID-19, purchasing intention, perceived behavioral control, and subjective norms. The findings indicate that HA has a significant impact on ATT. Furthermore, the results revealed that HA significantly influences ATT, ATT has a significant influence on PI, KN has a significant influence on ATT, KN has a significant influence on PI, PBC positively influences PI, SN has a significant influence over PI, and SN positively influences PI.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135967076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Potential of Traditional Medicinal Plants from Algeria for Treatment of Liver Diseases 阿尔及利亚传统药用植物治疗肝病的潜力
Jordan Journal of Pharmaceutical Sciences Pub Date : 2023-09-23 DOI: 10.35516/jjps.v16i3.685
Djahra Ali Boutlelis, Chrait Sabrina, Benkaddour Mounia, Benkherara Salah, Laib Ibtissam, Benine Chaima
{"title":"Therapeutic Potential of Traditional Medicinal Plants from Algeria for Treatment of Liver Diseases","authors":"Djahra Ali Boutlelis, Chrait Sabrina, Benkaddour Mounia, Benkherara Salah, Laib Ibtissam, Benine Chaima","doi":"10.35516/jjps.v16i3.685","DOIUrl":"https://doi.org/10.35516/jjps.v16i3.685","url":null,"abstract":"The objective of our study is to conduct an ethnobotanical investigation of traditional medicinal plants used by people in El-Oued state, southeast Algeria, for the treatment of liver diseases. We collected data through personal interviews and questionnaires. In total, we conducted interviews with 156 respondents, the majority of whom were aged 50 or older. Our study of medicinal plants used for treating liver diseases led to the discovery of 78 species from 41 families and various genera, including 52% of medicinal plants found in the wild. Approximately 77% of these plants were primarily used in dried form for remedy preparation. The most commonly employed preparation method was decoction. Interestingly, 70% of the participants mentioned Zizyphus lotus (L.) Lam., Silybum marianum L., and Atriplex halimus L. as sources for treating liver illnesses. This investigation revealed that many people in the research region still rely on herbal remedies to treat liver disorders. Moreover, the present study provides valuable ethnobotanical data on medicinal plants, serving as a foundational resource for future extensive research in this field.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":"63 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135967094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Diuretic Property of Argemone mexicana along with Molecular Docking Study 银银酮利尿性能评价及分子对接研究
Jordan Journal of Pharmaceutical Sciences Pub Date : 2023-09-23 DOI: 10.35516/jjps.v16i3.430
Pabitra Kumar Sardar, Hiron Saraj Devnath, Nripendra Nath Biswas, Bishwajit Bokshi, Samir Kumar Sadhu
{"title":"Evaluation of Diuretic Property of Argemone mexicana along with Molecular Docking Study","authors":"Pabitra Kumar Sardar, Hiron Saraj Devnath, Nripendra Nath Biswas, Bishwajit Bokshi, Samir Kumar Sadhu","doi":"10.35516/jjps.v16i3.430","DOIUrl":"https://doi.org/10.35516/jjps.v16i3.430","url":null,"abstract":"Background: Argemone mexicana L. (A. mexicana) has traditionally been used to treat hypertension, urinary issues, and constipation. In this study, we assessed the diuretic activity of the ethanolic crude extract of A. mexicana. Methods: Phytochemical tests were conducted using standard reagents and methods widely accepted in the field. The diuretic test was performed in metabolic cages using a mouse model, with furosemide (5 mg/kg) as the standard drug. Molecular docking was carried out in PyRx using Autodock Vina 4.2. To assess the stability of the protein-ligand complexes formed during docking, we conducted molecular dynamics (MD) simulations for the β-amyrin-6PZT protein complex and the furosemide-6PZT protein complex. Various parameters, including RMSD, RMSF, Rg, SASA, and hydrogen bonds, were calculated for all protein-ligand complexes. Results: Phytochemical screening revealed the presence of alkaloids, flavonoids, glycosides, steroids, terpenoids, saponins, and tannins in the crude extract. The crude extract exhibited significant (p < 0.05) diuretic activity compared to the control group. Furthermore, we detected the presence of electrolytes (Na+, K+, and Cl-) in the urine of mice treated with the crude extract. In the molecular docking study, among the eighteen compounds studied, β-amyrin displayed superior diuretic potential. The results of the molecular dynamics simulation for the β-amyrin-6PZT protein complex indicated good stability, comparable to the reference drug, furosemide. Conclusion: The crude extract of A. mexicana demonstrates significant diuretic effects that could be valuable for edema treatment. The findings from the molecular docking and molecular dynamics simulations suggest the potential for further research in developing a novel drug.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":"136 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135966016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of the Fungicidal and Nematicidal Potential of Reichardia tingitana (L.) Roth on Phytopathogenic Fungi and Plant Nematode 金针菇(Reichardia tingitana, L.)的杀真菌和杀线虫潜能评价植物病原真菌与植物线虫研究进展
Jordan Journal of Pharmaceutical Sciences Pub Date : 2023-09-23 DOI: 10.35516/jjps.v16i3.529
Abeer M. ElSayed, Ghena M. Abdel Razek, Abeer E. EL-Hadidy, Sabah H. El Gayed, Omer Sabry
{"title":"Assessment of the Fungicidal and Nematicidal Potential of Reichardia tingitana (L.) Roth on Phytopathogenic Fungi and Plant Nematode","authors":"Abeer M. ElSayed, Ghena M. Abdel Razek, Abeer E. EL-Hadidy, Sabah H. El Gayed, Omer Sabry","doi":"10.35516/jjps.v16i3.529","DOIUrl":"https://doi.org/10.35516/jjps.v16i3.529","url":null,"abstract":"The primary concern was the removal of numerous soil fumigants and nematicides due to their potential risks to human and environmental safety. Fungal pathogens can cause serious diseases in humans and animals. Among these, root-knot nematodes such as Meloidogyne incognita and Tylenchulus semipenetrans pose a significant threat, leading to substantial damage and yield reduction in various economically important plants. Therefore, this study aimed to assess the fungicidal and nematicidal activities of the ethanol extract (EE) and lupeol (L), the major isolates from the aerial parts of Reichardia tingitana L. Roth (Asteraceae), against Aspergillus flavus and plant-parasitic nematodes. Antifungal actions of EE (10-120 ppm) and L (23.4-281.2 µM) were evaluated through in vitro and in vivo growth assays, spore germination inhibition assays, and the efficacy of inhibiting pod and kernel infection. Nematicidal activity of EE and L was tested by preparing cultures containing egg masses of nematode species M. incognita from infected eggplants and T. semipenetrans from infected citrus roots, using concentrations of 2.5, 5, 10, 20, 40, 80, and 120 ppm. Results showed that R. tingitana (EE) and (L) exhibited nematostatic or nematicidal effects on nematode viability, egg hatch in vitro, and development and reproduction in vivo. Lupeol was particularly effective in inhibiting the colonization of A. flavus in peanuts. EE and L demonstrated high toxicity against nematodes in laboratory exposure and were effective in controlling nematode infestation in eggplant roots for 45 days. Improvement in plant growth parameters, including shoot and root length and weights, varied and was proportional to the doses of EE and L treatments. The antifungal and bio-nematicide effects of the ethanol extract from the aerial parts of R. tingitana were superior to those of lupeol, which could be attributed to the synergistic effect of phytochemicals in the ethanol extract. Both EE and L have potential applications as antifungal and bio-nematicide agents.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135967096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety of Adalimumab: An Analysis of the FDA Adverse Event Reporting System (FAERS) Database 阿达木单抗安全性:FDA不良事件报告系统(FAERS)数据库分析
Jordan Journal of Pharmaceutical Sciences Pub Date : 2023-09-23 DOI: 10.35516/jjps.v16i3.629
Buthainah Ghanem
{"title":"Safety of Adalimumab: An Analysis of the FDA Adverse Event Reporting System (FAERS) Database","authors":"Buthainah Ghanem","doi":"10.35516/jjps.v16i3.629","DOIUrl":"https://doi.org/10.35516/jjps.v16i3.629","url":null,"abstract":"Objective: This study aims to assess the safety profile of adalimumab and its biosimilars for each approved indication by analyzing adverse events (AEs) reported in the FDA Adverse Event Reporting System (FAERS) database. Method: We conducted a retrospective pharmacovigilance analysis of AE reports documented from 2002 to 2022 in the FAERS database. This analysis included descriptive statistics and binary logistic regression analyses. We calculated reporting odds ratios (RORs) with 95% confidence intervals (CI) to investigate safety signals related to the disproportionate reporting of serious AEs for adalimumab and its biosimilars compared to currently available biological products for the same proposed indications. Results: A total of 543,873 AEs related to adalimumab treatment were reported, with 49.8% classified as serious. Hospitalization was the most frequently reported AE. Risk factors associated with serious AEs included age (≥60 years), male sex, and the concurrent use of adalimumab (ROR >1, P<0.05). Adalimumab exhibited a lower risk of serious AEs compared to abatacept, certolizumab, infliximab, or rituximab. Conversely, etanercept and ixekizumab showed lower odds of serious AEs than adalimumab (ROR <1, P<0.05). Conclusion: In summary, these findings suggest that adalimumab has a well-tolerated safety profile for approved indications when compared to currently available biological alternatives.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135966853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Blood Pressure in Children Treated with Ceftriaxone: A Case-Control Study 头孢曲松治疗儿童血压的评估:一项病例对照研究
Jordan Journal of Pharmaceutical Sciences Pub Date : 2023-09-23 DOI: 10.35516/jjps.v16i3.1608
Mahdi Esmaeili, Roham Sarmadian, Gholamali Fatahibayat, Parsa Yousefichaijan, Danial Habibi
{"title":"Evaluation of Blood Pressure in Children Treated with Ceftriaxone: A Case-Control Study","authors":"Mahdi Esmaeili, Roham Sarmadian, Gholamali Fatahibayat, Parsa Yousefichaijan, Danial Habibi","doi":"10.35516/jjps.v16i3.1608","DOIUrl":"https://doi.org/10.35516/jjps.v16i3.1608","url":null,"abstract":"Background: In children, high blood pressure can develop into hypertension and its consequences during puberty and adulthood. High blood pressure in children is often secondary to other causes, including renal diseases. Nephrolithiasis is one of the causes of secondary hypertension. The extensive use of cephalosporins in hospitals, particularly ceftriaxone, can result in nephrolithiasis. Therefore, the purpose of this study was to assess the relationship between ceftriaxone treatment and elevated blood pressure in children. Method: The research was conducted as a case-control study over an 18-month period from 2018 to 2019. In this study, blood pressure was measured in 111 children aged 3-13 years who were hospitalized at Amir Kabir Hospital in Arak and received ceftriaxone for at least 48 hours. As a control group, 111 children who did not receive ceftriaxone had their blood pressure measured. The blood pressure levels and percentiles of children in the two groups were then compared. Result: In the case and control groups, the mean age was 5.1±1.61 and 6.04±2.4 years, and the mean height was 109.17±10.71 and 114.86±12.95 cm, respectively. A slightly higher mean systolic blood pressure percentile was observed in the case group (65.59±18.17) than in the control group (65.28±14.51) (P=0.112), and the mean diastolic blood pressure percentile was also slightly higher in the case group (58.89±18.88) than in the control group (54.85±19.28) (P=0.317). The difference in diastolic blood pressure was greater than in systolic blood pressure. However, these detected differences were slight and not statistically significant. Conclusion: This study showed no association between blood pressure levels and ceftriaxone treatment in children older than three years who received the medicine for at least 48 hours. However, additional research is suggested, focusing on the effects of the medicine at higher doses and over a longer period of time following administration.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135967086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decriminalization of Narcotics in Jordanian Legislation: Theory and Practice 约旦立法中麻醉品非刑事化:理论与实践
Jordan Journal of Pharmaceutical Sciences Pub Date : 2023-09-23 DOI: 10.35516/jjps.v16i3.722
Khalid Abdulrahman Alhrerat, Zainab Zakaraya, Wael Abu Dayyih, Mohammad Hailat, Mohammed Hamad, Ibrahim Alabbadi
{"title":"Decriminalization of Narcotics in Jordanian Legislation: Theory and Practice","authors":"Khalid Abdulrahman Alhrerat, Zainab Zakaraya, Wael Abu Dayyih, Mohammad Hailat, Mohammed Hamad, Ibrahim Alabbadi","doi":"10.35516/jjps.v16i3.722","DOIUrl":"https://doi.org/10.35516/jjps.v16i3.722","url":null,"abstract":"This study delves into recent legislation in Jordan regarding the decriminalization of narcotics and traces the evolution of related legislation in the country. It explores the definition and underlying philosophy of decriminalization while examining arguments from both proponents and opponents of drug decriminalization from a jurisprudential perspective. Additionally, the research sheds light on practices that have emerged in response to the decriminalization of narcotics in other jurisdictions. The study thoroughly examines the advantages and disadvantages of decriminalizing narcotics, analyzing its potential impact on drug consumption. Finally, the researcher proposes the implementation of a gradual and partial systematic plan within Jordanian legislation to address the growing trend of drug decriminalization. The paper also provides insights into the stances of the United States and other countries on this issue and how their legislations have addressed it.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":"73 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135967338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantification of Mangiferin from the Bioactive Fraction of Mango Leaves (Mangifera indica L.) and Evaluation of Wound-Healing Potential 芒果叶生物活性成分中芒果苷的含量测定及创面愈合电位评价
Jordan Journal of Pharmaceutical Sciences Pub Date : 2023-09-23 DOI: 10.35516/jjps.v16i3.652
Valdy Filando Sardi, Astika Astika, Ilza Milenia Jalius, Friardi Ismed
{"title":"Quantification of Mangiferin from the Bioactive Fraction of Mango Leaves (Mangifera indica L.) and Evaluation of Wound-Healing Potential","authors":"Valdy Filando Sardi, Astika Astika, Ilza Milenia Jalius, Friardi Ismed","doi":"10.35516/jjps.v16i3.652","DOIUrl":"https://doi.org/10.35516/jjps.v16i3.652","url":null,"abstract":"Burns refer to damage to the skin's surface caused by exposure to high temperatures, which can be due to factors such as oil, water, electricity, fire, sun exposure, and chemicals. Prompt and appropriate treatment is essential to prevent undesirable consequences. Thus, this study aimed to quantify mangiferin, a potential treatment for burns, in the bioactive fraction of mango leaves (Mangifera indica L.) and evaluate its effectiveness in healing burns.The methods employed included thin-layer chromatography (TLC)-densitometry with validation measures, including linearity, detection and quantification limits (LoD and LoQ), precision, accuracy, and quantification. The bioactive fraction was formulated in membranes at concentrations of 5%, 10%, and 15%. These membranes were applied to rabbits previously subjected to six wound burns, and the healing progress was monitored by measuring burn diameter using a vernier caliper every 3 days for a total of 21 days. Mangiferin, the active compound, was detected at a wavelength of 257 nm. Test results yielded a linearity equation, y = 76496x + 2935.7, with a correlation coefficient value of 0.9957, a detection limit of 2.01 µg/mL, a quantification limit of 6.07 µg/mL, a coefficient of variation ranging from 0.59% to 3.33%, and an accuracy range of 99.18% to 100.9%, with mangiferin levels at 208.31 µg/mL. The membrane preparations of the bioactive mangiferin fraction were evaluated on second-degree burns in rabbits, with concentrations of 10% and 15% showing the most effectiveness.","PeriodicalId":14719,"journal":{"name":"Jordan Journal of Pharmaceutical Sciences","volume":"99 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135965496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信